Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different
pace. Early markers of disease progression could facilitate and improve patient …

Given the pathophysiological continuum of chronic kidney disease (CKD), different
molecular determinants affecting progression may be associated with distinct disease …

Chronic kidney disease (CKD) is a non-specific type of kidney disease that causes a gradual
decline in kidney function (from months to years). CKD is a significant risk factor for death …

In order to effectively develop personalized medicine for kidney diseases we urgently need
to develop highly accurate biomarkers for use in the clinic, since current biomarkers of …

Biomarker development, improvement, and clinical implementation in the context of kidney
disease have been a central focus of biomedical research for decades. To this point, only …

Urinary peptides gained significant attention as potential biomarkers especially in the
context of kidney and cardiovascular disease. In this manuscript the recent literature since …

Introduction Chronic kidney disease is avery common and complex chronic disease.
Uncovering the pathological patterns of CKD on the molecular level of bio-fluids and tissue …

The peptiCKDdb is a publicly available database platform dedicated to support research in
the field of chronic kidney disease (CKD) through identification of novel biomarkers and …

Background An improvement in the glomerular filtration rate (GFR) of chronic kidney disease
patients has been an underestimated clinical outcome. Although this may be considered as …

Exponential technologies double in power or processing speed every year, whereas their
cost halves. Deception and disruption are two key stages in the development of exponential …